These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22359071)

  • 1. Inflammation, atherosclerosis, and psoriasis.
    Siegel D; Devaraj S; Mitra A; Raychaudhuri SP; Raychaudhuri SK; Jialal I
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):194-204. PubMed ID: 22359071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?
    Sunbul M; Agirbasli M
    Curr Pharm Des; 2014; 20(4):529-35. PubMed ID: 23565636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center.
    Santilli S; Kast DR; Grozdev I; Cao L; Feig RL; Golden JB; Debanne SM; Gilkeson RC; Orringer CE; McCormick TS; Ward NL; Cooper KD; Korman NJ
    J Transl Med; 2016 Jul; 14(1):217. PubMed ID: 27448600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis, some serum inflammatory markers in psoriasis.
    Alpsoy S; Akyuz A; Erfan G; Akkoyun DC; Topcu B; Guzel S; Kaya S; Kulac M
    G Ital Dermatol Venereol; 2014 Apr; 149(2):167-75. PubMed ID: 24819636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis.
    Pirro M; Stingeni L; Vaudo G; Mannarino MR; Ministrini S; Vonella M; Hansel K; Bagaglia F; Alaeddin A; Lisi P; Mannarino E
    Eur J Prev Cardiol; 2015 Aug; 22(8):1027-35. PubMed ID: 24906366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
    Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model.
    Aksentijevich M; Lateef SS; Anzenberg P; Dey AK; Mehta NN
    Trends Cardiovasc Med; 2020 Nov; 30(8):472-478. PubMed ID: 31837960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRP and the risk of atherosclerotic events.
    Calabrò P; Golia E; Yeh ET
    Semin Immunopathol; 2009 Jun; 31(1):79-94. PubMed ID: 19415283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
    Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
    BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.
    Shlyankevich J; Mehta NN; Krueger JG; Strober B; Gudjonsson JE; Qureshi AA; Tebbey PW; Kimball AB
    Am J Med; 2014 Dec; 127(12):1148-53. PubMed ID: 25149424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis and cardiovascular comorbidities with emphasis in Asia.
    Chu TW; Tsai TF
    G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Immunological Links Between Psoriasis and Cardiovascular Disease.
    Sajja AP; Joshi AA; Teague HL; Dey AK; Mehta NN
    Front Immunol; 2018; 9():1234. PubMed ID: 29910818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Associations Between Neutrophils, Atherosclerosis, and Psoriasis.
    Sanda GE; Belur AD; Teague HL; Mehta NN
    Curr Atheroscler Rep; 2017 Oct; 19(12):53. PubMed ID: 29086088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic Disorders in Psoriatic Disease.
    Sobchak C; Eder L
    Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis in Psoriasis: Cutaneous Cytokine Production as a Potential Driving Force of Haemostatic Dysregulation and Subsequent Cardiovascular Risk.
    Visser MJE; Tarr G; Pretorius E
    Front Immunol; 2021; 12():688861. PubMed ID: 34335591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
    Joshi AA; Lerman JB; Aberra TM; Afshar M; Teague HL; Rodante JA; Krishnamoorthy P; Ng Q; Aridi TZ; Salahuddin T; Natarajan B; Lockshin BN; Ahlman MA; Chen MY; Rader DJ; Reilly MP; Remaley AT; Bluemke DA; Playford MP; Gelfand JM; Mehta NN
    Circ Res; 2016 Nov; 119(11):1242-1253. PubMed ID: 27654120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.